Life Technologies

Life Technologies Parkinson’s disease cell models—part 3

Issue link: http://life-technologies.uberflip.com/i/368629

Contents of this Issue

Navigation

Page 21 of 33

22 Life Technologies ™ | Parkinson's cell models After analyzing the TaqMan ® SNP Genotyping Assay results from each plating of cells, Ion PGM ™ sequencing was then performed on candidate colonies to assess clonality and to characterize the second allele deletion. For the final selected clonal population, sequencing showed that the original 2 bp deletion was now present in all cells, and half of the sequences lacked an additional 6 bases flanking these 2 bases (Figure 10). The identified deletions were further verified by Sanger sequencing. Figure 10. Ion PGM ™ sequencing of the edited iPSC clone with SNCA -/- . (A) Percent of reads containing a deletion shown as a function of nucleotide position. (B) IGV software clearly indicates an 8 bp deletion on the second allele. Nucleotide Percent deleted 1 51 2 51 3 99 4 99 5 52 6 40 7 39 8 39 A B Generation of α-synuclein knockout lines from the MSA line (continued) 1 2 3 4 5 6 7 8 SNCA -/ - edit – IGV viewer SNCA -/- edit as shown in IGV 8 7 6 5 4 3 2 1 The QuantStudio ® 12K Flex Real-Time PCR System is an all-in-one instrument designed for maximum throughput, flexibility, and scalability. The QuantStudio ® 12K Flex system was used to determine the presence of specific mutations in each colony (Figures 4 and 9) and to assess the pluripotency status of double mutant colonies (Figure 11C). Learn more at lifetechnologies.com/quantstudio12k Instrument highlight—QuantStudio ® 12K Flex Real-Time PCR System

Articles in this issue

Links on this page

view archives of Life Technologies - Life Technologies Parkinson’s disease cell models—part 3